Benjamin F. Edwards & Company’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$5K Sell
36
-202
-85% -$23.3K ﹤0.01% 1856
2024
Q1
$27K Sell
238
-7,935
-97% -$946K ﹤0.01% 1445
2023
Q4
$1.06M Buy
8,173
+64
+0.8% +$8.82K 0.02% 476
2023
Q3
$1.32M Buy
+8,109
New +$1.43M 0.05% 311

Other funds holding ACLS

Benjamin F. Edwards & Company's ACLS Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Axcelis (ACLS) stake by 85% in Q2 2024, selling an estimated $23.3K and leaving 36 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

Benjamin F. Edwards & Company first reported a position in ACLS in Q3 2023 and has held it in 4 quarters since. The position peaked at $1.32M in Q3 2023. 392 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.

  • Benjamin F. Edwards & Company held 36 shares of Axcelis worth $5K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 202 Axcelis shares in Q2 2024, an estimated $23.3K.
  • Axcelis made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1856 holding.
  • Benjamin F. Edwards & Company first reported a position in Axcelis in Q3 2023 and has held it in 4 quarters since.
  • Benjamin F. Edwards & Company's Axcelis position peaked at $1.32M in Q3 2023.
  • 392 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.